Spurious toxic vancomycin levels

European Journal of Internal Medicine

Volumn 19, Issue 6, 2008, Pages

  Naschitz, Jochanan E ^a,c   Gagarin, Andrey ^a   Schor, Ruth Gropper ^a,b  

^a Flieman Geriatric Rehabilitation Hospital   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Spurious; Vancomycin; Venous catheter

Indexed keywords

ACETYLSALICYLIC ACID; CARVEDILOL; METFORMIN; RAMIPRIL; RIFAMPICIN; SIMVASTATIN; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; HUMAN; MALE; OSTEOMYELITIS; REMISSION; RETREATMENT; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CATHETERIZATION, CENTRAL VENOUS; HUMANS; MALE; MIDDLE AGED; VANCOMYCIN;

EID: 51449120739     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2008.01.007     Document Type: Article

References (6)

1. Deresinski S. Vancomycin: does it still have a role as an antistaphylococcal agent?. Expert Rev Anti Infect Ther 5 (2007) 393-401
2. Bunchman T.E., Valentini R.P., Gardner J., Mottes T., Kudelka T., and Maxvold N.J. Treatment of vancomycin overdose using high-efficiency dialysis membranes. Pediatr Nephrol 13 (1999) 773-774
3. Vercaigne L.M., Sitar D.S., Penner S.B., Bernstein K., Wang G.Q., and Burczynski F.J. Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter. Pharmacotherapy 20 (2000) 394-399
4. Anthony T.U., and Rubin L.G. Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports). Antimicrob Agents Chemother 43 (1999) 2074-2076
5. Haimi-Cohen Y., Husain N., Meenan J., Karayalcin G., Lehrer M., and Rubin L.G. Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique. Antimicrob Agents Chemother 45 (2001) 1565-1567
6. Bastani B., Minton J., and Islam S. Insufficient penetration of systemic vancomycin into the PermCath lumen. Nephrol Dial Transplant 15 (2000) 1035-1037